Medicare Enrolled
Megha Shah
Hematology & Oncology · Flemington, NJ
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Shah from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Shah?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Shah
Megha Shah is a hematology & oncology specialist in Flemington, NJ, with 17 years of NPI registration. Based on federal Medicare data, Shah performed 111,704 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Shah received a total of $13,157 from 78 pharmaceutical and/or device companies across 346 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Shah is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years of NPI registration
▲ Top 7% volume in NJ
$13,157 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗111,704
Medicare services
Top 7% in NJ for hematology & oncology
Not available
Unique patients (not deduplicated)
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
48,754 | $1 | $4 |
| Anti-nausea injection (aprepitant) | 16,515 | $1 | $5 |
| Paclitaxel protein-bound particle injection An injection of paclitaxel formulated as protein-bound particles. This code specifies the administration of the medication measured in milligrams. |
9,927 | $11 | $30 |
| Injection, granisetron, extended-release, 0.1 mg | 8,800 | $5 | $15 |
| Pembrolizumab injection (Keytruda) | 8,001 | $43 | $115 |
| Denosumab injection (Prolia/Xgeva) | 7,566 | $18 | $49 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
2,497 | $0 | $1 |
| Anti-nausea injection (ondansetron/Zofran) | 952 | $0 | $1 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
853 | $8 | $51 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
853 | $6 | $39 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
846 | $76 | $229 |
| Anti-nausea injection (Aloxi/palonosetron) | 509 | $1 | $37 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
473 | $13 | $127 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
414 | $27 | $661 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
395 | $10 | $164 |
| Pegfilgrastim injection, 0.5 mg An injection of pegfilgrastim, a medication that stimulates the production of white blood cells. This specific code applies to the brand-name drug and excludes biosimilar versions. |
374 | $71 | $667 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
366 | $6 | $29 |
| Magnesium sulfate injection, per 500 mg An injection of magnesium sulfate administered in 500 mg increments. |
346 | $1 | $1 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
316 | $123 | $1,023 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
297 | $7 | $32 |
| Phosphate level test A blood test that measures the amount of phosphate in your body. Phosphate is a mineral that helps keep bones and teeth strong. |
290 | $5 | $22 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
280 | $2 | $20 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
228 | $8 | $24 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
212 | $12 | $661 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
170 | $60 | $691 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
155 | $156 | $518 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
152 | $2 | $12 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
129 | $60 | $497 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
118 | $14 | $145 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
103 | $26 | $572 |
| New patient office visit, complex (60-74 min) | 90 | $194 | $746 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
80 | $30 | $551 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
73 | $68 | $235 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
69 | $1 | $4 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
67 | $18 | $123 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
62 | $31 | $269 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 56 | $20 | $99 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
45 | $69 | $309 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
40 | $19 | $674 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
40 | $1 | $12 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
38 | $112 | $323 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
25 | $19 | $90 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
23 | $29 | $162 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
21 | $104 | $334 |
| Free thyroxine (T4) test A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream. |
20 | $9 | $43 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
20 | $16 | $79 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
18 | $133 | $663 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
14 | $34 | $76 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
12 | $76 | $175 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
44.9% high complexity
51.5% medium
3.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$13,157
Total received (2018-2024)
Avg $1,880/year across 7 years
Top 23% in NJ for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
78
Companies
346
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$6,071
2023
$4,035
2022
$767
2021
$479
2020
$406
2019
$793
2018
$607
Payments by company (2024)
Alnylam Pharmaceuticals Inc.
$2,300
Daiichi Sankyo Inc.
$1,465
Novartis Pharmaceuticals Corporation
$1,055
AstraZeneca Pharmaceuticals LP
$142
GENZYME CORPORATION
$116
ABBVIE INC.
$76
BeiGene USA, Inc.
$57
Regeneron Healthcare Solutions, Inc.
$57
Lilly USA, LLC
$57
Gilead Sciences, Inc.
$53
Janssen Biotech, Inc.
$51
Astellas Pharma US Inc
$42
PFIZER INC.
$40
ARRAY BIOPHARMA INC
$40
Eisai Inc.
$36
GlaxoSmithKline, LLC.
$35
SpringWorks Therapeutics, Inc.
$34
E.R. Squibb & Sons, L.L.C.
$33
Celgene Corporation
$32
Incyte Corporation
$31
Tempus AI, Inc
$29
Genentech USA, Inc.
$22
Genmab U.S., Inc.
$22
TAIHO ONCOLOGY, INC.
$21
SERVIER PHARMACEUTICALS LLC
$19
Alexion Pharmaceuticals, Inc.
$19
Janssen Pharmaceuticals, Inc
$19
Celltrion USA Inc.
$19
Takeda Pharmaceuticals U.S.A., Inc.
$18
Fresenius Kabi USA, LLC
$17
Aveo Pharmaceuticals, Inc.
$17
Karyopharm Therapeutics Inc.
$17
Ipsen Biopharmaceuticals, Inc
$17
EMD Serono, Inc.
$17
Kyowa Kirin, Inc.
$17
Cumberland Pharmaceuticals, Inc.
$15
Stemline Therapeutics Inc.
$15
Top 3 companies account for 79.4% of 2024 payments
All-time payments by company (2018-2024) ›
Alnylam Pharmaceuticals Inc.
$2,300
Daiichi Sankyo Inc.
$2,054
Novartis Pharmaceuticals Corporation
$1,401
Mirati Therapeutics, Inc.
$882
AstraZeneca Pharmaceuticals LP
$840
Astellas Pharma US Inc
$787
Janssen Biotech, Inc.
$613
GENZYME CORPORATION
$224
Stemline Therapeutics Inc.
$189
Celltrion USA Inc.
$169
Takeda Pharmaceuticals U.S.A., Inc.
$163
Genentech USA, Inc.
$158
Gilead Sciences, Inc.
$154
Amgen Inc.
$153
Incyte Corporation
$147
Lilly USA, LLC
$145
Celgene Corporation
$142
Regeneron Healthcare Solutions, Inc.
$140
PFIZER INC.
$138
E.R. Squibb & Sons, L.L.C.
$134
Seagen Inc.
$132
BeiGene USA, Inc.
$91
ABBVIE INC.
$90
Eisai Inc.
$86
Merck Sharp & Dohme Corporation
$84
Seattle Genetics, Inc.
$83
GlaxoSmithKline, LLC.
$79
Puma Biotechnology, Inc.
$71
Bayer HealthCare Pharmaceuticals Inc.
$61
Exelixis Inc.
$60
GE HealthCare
$57
Foundation Medicine, Inc.
$57
Ipsen Biopharmaceuticals, Inc
$57
ARRAY BIOPHARMA INC
$56
Alexion Pharmaceuticals, Inc.
$50
Janssen Pharmaceuticals, Inc
$50
Kyowa Kirin, Inc.
$46
Pharmacyclics LLC, An AbbVie Company
$44
Apellis Pharmaceuticals, Inc.
$44
Taiho Oncology, Inc.
$43
Fresenius Kabi USA, LLC
$43
Myovant Sciences Inc.
$43
Aveo Pharmaceuticals, Inc.
$42
EISAI INC.
$41
Coherus Biosciences Inc.
$40
SERVIER PHARMACEUTICALS LLC
$39
Genmab U.S., Inc.
$39
SpringWorks Therapeutics, Inc.
$34
MorphoSys, US Inc.
$33
EMD Serono, Inc.
$32
Karyopharm Therapeutics Inc.
$31
AbbVie Inc.
$30
Blueprint Medicines Corporation
$30
Tempus AI, Inc
$29
Boehringer Ingelheim Pharmaceuticals, Inc.
$26
Dova Pharmaceuticals
$25
Heron Therapeutics, Inc.
$24
Adaptive Biotechnologies Corporation
$23
TAIHO ONCOLOGY, INC.
$21
Pharmacyclics LLC, an AbbVie Company
$20
Ferring Pharmaceuticals Inc.
$17
Cumberland Pharmaceuticals, Inc.
$15
Servier Pharmaceuticals LLC
$15
MEDIVATION FIELD SOLUTIONS LLC
$15
AVEO Pharmaceuticals, Inc.
$15
Bayer Healthcare Pharmaceuticals Inc.
$15
Helsinn Therapeutics (U.S.), Inc.
$15
Rigel Pharmaceuticals, Inc.
$14
TerSera Therapeutics LLC
$14
Organon LLC
$13
Clovis Oncology, Inc.
$13
Octapharma USA, Inc.
$12
Kite Pharma, Inc.
$12
AMAG Pharmaceuticals, Inc.
$12
Epizyme, Inc.,
$12
AbbVie, Inc.
$11
Fortovia Therapeutics, Inc.
$10
Secura Bio, Inc.
$10
Top 3 companies account for 43.7% of all-time payments
Associated products mentioned in payments ›
ABECMA · ADCETRIS · AKYNZEO · ALUNBRIG · AYVAKIT · Alecensa · BAVENCIO · BLENREP · BRUKINSA · Blincyto · CABOMETYX · CALQUENCE · COSELA · CYRAMZA · Cabometyx · DARZALEX · Doptelet · ELAHERE · ELITEK · ELREXFIO · EMEND · ENHERTU · EPKINLY · ERLEADA · EVENITY · Empaveli · Enhertu · Epkinly · Erleada · FARESTON · FARXIGA · FARYDAK · FERAHEME · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · GILOTRIF · GIVLAARI · Halaven · Herceptin · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INFLECTRA · INJECTAFER · Imbruvica · JADENU · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · NERLYNX · NETSPOT · NINLARO · Nerlynx · Neulasta · Nubeqa · OGSIVEO · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Onivyde · Orserdu · PADCEV · PANZYGA · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · Padcev · Pomalyst · Poteligeo · REBLOZYL · REBYOTA · RECOTHROM · Revlimid · Rubraca · SANCUSO · SANDOSTATIN · SARCLISA · SCEMBLIX · SOMATULINE DEPOT · SUSTOL · Somatuline Depot · Stimufend · Stivarga · TAZVERIK · TECENTRIQ · TECVAYLI · TEVIMBRA · TIBSOVO · TUKYSA · Tavalisse · Tibsovo · Trodelvy · ULTOMIRIS · Udenyca · VARUBI · VEGZELMA · VENCLEXTA · VERZENIO · Venclexta · XALKORI · XARELTO · XPOVIO · XTANDI · Xofigo · Xtandi · Yescarta · ZEJULA · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
81
County median income
$139,453
Nearest hospital to ZIP centroid (approximate)
HUNTERDON MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Shah is a mixed practice specialist, with above-average Medicare volume (top 7% in NJ), with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Shah experienced with iron infusion (injectafer)?
Based on Medicare claims data, Shah performed 48,754 iron infusion (injectafer) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Shah receive payments from pharmaceutical companies?
Yes. Shah received a total of $13,157 from 78 companies across 346 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Shah's costs compare to other hematology & oncology specialists in Flemington?
Shah's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Shah) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Flemington
Browse hematology & oncology specialists in Flemington ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in NJ
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in NJ
Which NJ hematology & oncology specialists receive the most from drug and device companies.
By company
Alnylam Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Alnylam Pharmaceuticals Inc.
By company
Daiichi Sankyo Inc. Payments to Doctors
See all physicians who received payments from Daiichi Sankyo Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology